Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-04-15

Clinical Trial Update: Mesenchymal Stem Cells for the Treatment of Pouch Fistulas in Crohn's [Phase 1]

View source ↗

Summary

The ClinicalTrials.gov entry shows a Phase 1 trial investigating mesenchymal stem cells for pouch fistulas in Crohn's disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Crohn's Disease, Fistula | Phase 1 | Status: WITHDRAWN